Invokana Plagued by New FDA Warnings and Lawsuits

Invokana Plagued by New FDA Warnings and Lawsuits

When it was first announced—with the help of aggressive marketing—Invokana was hailed as an exciting development in the world of diabetes treatment and the first of a promising new generation…

More in Health >
FDA Advisory Panel Votes to Allow Claim Regarding Jardiance Cardiovascular  Events

FDA Advisory Panel Votes to Allow Claim Regarding Jardiance Cardiovascular Events

A US Food and Drug Administration (FDA) advisory panel has narrowly voted to approve a Jardiance claim that the drug can decrease the risk of cardiovascular death. Jardiance (empagliflozin), an…

More in Health >
FDA Explores Invokana Increasing the Risk for Amputation?

FDA Explores Invokana Increasing the Risk for Amputation?

The FDA has issued a recent safety communication warning the public of the famous diabetes medicine canagliflozin. The safety issue was in relation to an ongoing  interim clinical trial that found…

More in Health >